The age of the target cell affects B-cell leukaemia malignancy

Aging

Volumn 2, Issue 12, 2010, Pages 908-913

  Vicente Dueñas, Carolina ^a   Abollo Jiménez, Fernando ^a,b   Ruiz Roca, Lucía ^a   Alonso Escudero, Esther ^a   Jiménez, Rafael ^a   Cenador, María Begoña García ^a   Criado, Francisco Javier García ^a   Cobaleda, César ^b   Sánchez García, Isidro ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Age; B cell leukaemia; BCR ABL; Target cell

Indexed keywords

ABL BCR FUSION PROTEIN, HUMAN; ABL-BCR FUSION PROTEIN, HUMAN; BCR ABL PROTEIN;

AGE; ANIMAL; ARTICLE; B CELL LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER INVASION; CANCER STEM CELL; CELL AGING; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; EXPERIMENTAL LEUKEMIA; GENETICS; HUMAN; METABOLISM; MOUSE; ONCOGENE; PATHOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; BONE MARROW TRANSPLANTATION; CELL AGING; CELL LINE; CELL SURVIVAL; FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS;

EID: 79952257743     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100244     Document Type: Article

References (22)

1. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukaemia in adults. Blood. 1995; 85: 1151-1168.
2. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003; 3: 639-649.
3. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukaemia. N Engl J Med. 2004; 350: 1535-1548.
4. Cobaleda C, Sanchez-Garcia I. B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. Bioessays. 2009; 31: 600-609.
5. Hjalgrim LL, Rostgaard K, Schmiegelow K, Soderhall S, Kolmannskog S, Vettenranta K, Kristinsson J, Clausen N, Melbye M, Hjalgrim H, Gustafsson G. Age- and sex-specific incidence of childhood leukaemia by immunophenotype in the Nordic countries. J Natl Cancer Inst. 2003; 95: 1539-1544.
6. Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L, Tafuri A, Vignetti M, Vitale A, Cuneo A, Castoldi G, Saglio G, Pane F, et al. A comprehensive genetic classification of adult acute lymphoblastic leukaemia (ALL): analysis of the GIMEMA 0496 protocol. Blood. 2005; 105: 3434-3441.
7. Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman IL, Bryder D, Rossi DJ. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A. 107: 5465-5470.
8. Gazit R, Weissman IL, Rossi DJ. Hematopoietic stem cells and the aging hematopoietic system. Semin Hematol. 2008; 45: 218-224.
9. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med. 1996; 2: 1011-1016.
10. Rossi DJ, Bryder D, Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol. 2007; 42: 385-390.
11. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. 2005; 102: 9194-9199.
12. Rossi DJ, Seita J, Czechowicz A, Bhattacharya D, Bryder D, Weissman IL. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle. 2007; 6: 2371-2376.
13. Allman D, Miller JP. The aging of early B-cell precursors. Immunol Rev. 2005; 205: 18-29.
14. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004; 5: 133-139.
15. Miller JP, Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol. 2003; 171: 2326-2330.
16. Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, Akashi K, Gilliland DG. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004; 6: 587-596.
17. Cobaleda C, Gutierrez-Cianca N, Perez-Losada J, Flores T, Garcia-Sanz R, Gonzalez M, Sanchez-Garcia I. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukaemia. Blood. 2000; 95: 1007-1013.
18. Cox CV, Evely RS, Oakhill A, Pamphilon DH, Goulden NJ, Blair A. Characterization of acute lymphoblastic leukaemia progenitor cells. Blood. 2004; 104: 2919-2925.
19. Cobaleda C, Sanchez-Garcia I. In vivo inhibition by a sitespecific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. Blood. 2000; 95: 731-737.
20. Perez-Caro M, Gutierrez-Cianca N, Gonzalez-Herrero I, Lopez-Hernandez I, Flores T, Orfao A, Sanchez-Martin M, Gutierrez-Adan A, Pintado B, Sanchez-Garcia I. Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice. Oncogene. 2007; 26: 1702-1713.
21. Henry CJ, Marusyk A, Zaberezhnyy V, Adane B, Degregori J. Declining lymphoid progenitor fitness promotes agingassociated leukemogenesis. Proc Natl Acad Sci U S A. 2010; doi/10.1073/pnas.1005486107.
22. Schebesta A, McManus S, Salvagiotto G, Delogu A, Busslinger GA, Busslinger M. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity. 2007; 27: 49-63.